Inhibitory Effects of Ginsenoside-Rb1 on Activation of the 12-O-Tetradecanoylphorbol 13-Acetate-Induced Cyclooxygenase-2 Promoter

Abstract

We studied the inhibitory effects of ginsenoside-Rb1 (1) on 12-O-tetradecanoylphorbol 13-acetate (TPA)-induced transcriptional activation of the cyclooxygenase-2 (COX-2) promoter. The suppressive activity of ginsenoside-Rb1 was characterized using COX-2 promoter-driven luciferase reporter plasmids in a transient transfection system. Ginsenoside-Rb1 at 100 μM inhibited TPA-induced transcriptional activation of the COX-2 promoter. To identify the cis-acting elements responsible for this inhibition, the effects of site-specific mutations in the COX-2 promoter region were examined. Inhibition by ginsenoside-Rb1 was not affected by mutations in nuclear factor-κB- or cAMP-responsive elements. However, the effects were abolished when the nuclear factor-interleukin-6 binding site was mutated, indicating that ginsenoside-Rb1 exerts its effects via this element. In conclusion, ginsenoside-Rb1 inhibits TPA-induced COX-2 promoter activity through the nuclear factor interleukin-6 binding site and not through the nuclear factor-κB or cAMP-responsive elements.

References

• 1 Attele A S, Wu J A, Yuan C S. Ginseng pharmacology: multiple constituents and multiple actions.  Biochem Pharmacol. 1999;  58 1685-93
• 2 Liu W K, Xu S X, Che C T. Anti-proliferative effect of ginseng saponins on human prostate cancer cell line.  Life Sci. 2000;  67 1297-306
• 3 Yoon M, Lee H, Jeong S, Kim J J, Nicol C J, Nam K W. et al . Peroxisome proliferator-activated receptor alpha is involved in the regulation of lipid metabolism by ginseng.  Br J Pharmacol. 2003;  138 1295-302
• 4 Shibata S. Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds.  J Korean Med Sci. 2001;  16 (Suppl) S28-S37
• 5 Morschl E, Bretus I, Nemcsik J, Laszlo F, Pavo I. Estrogen-mediated up-regulation of the Ca-dependent constitutive nitric oxide synthase in the rat aorta and heart.  Life Sci. 2000;  68 49-55
• 6 Scott G I, Colligan P B, Ren B H, Ren J. Ginsenosides Rb1 and Re decrease cardiac contraction in adult rat ventricular myocytes: role of nitric oxide.  Br J Pharmacol. 2001;  134 1159-65
• 7 Kim H S, Zhang Y H, Fang L H, Lee M K. Effects of ginsenosides on bovine adrenal tyrosine hydroxylase.  J Ethnopharmacol. 1999;  66 107-11
• 8 Cho J Y, Park W K, Lee S G, Ahn W S, Lee Y J. Ginsenoside-Rb1 from Panax ginseng C.A. Meyer activates estrogen receptor-alpha and -beta, independent of ligand binding.  J Clin Endocrinol Metab. 2004;  89 3510-5
• 9 Funk C D, Funk L B, Kennedy M E, Pong A S, Fitzgerald G A. Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment.  FASEB J. 1991;  5 2304-12
• 10 Smith W L, DeWitt D L, Garavito R M. Cyclooxygenases: structural, cellular, and molecular biology.  Annu Rev Biochem. 2000;  69 45-82
• 11 Chen C C, Sun Y T, Chen J J, Chiu K T. TNF-alpha-induced cyclooxygenase-2 expression in human lung epithelial cells: involvement of the phospholipase C-gamma 2, protein kinase C-alpha, tyrosine kinase, NF-kappa B-inducing kinase, and I-kappa B kinase 1/2 pathway.  J Immunol. 2000;  165 2719-28
• 12 Chen Y, Yang L, Lee T J. Oroxylin A inhibition of lipopolysaccharide-induced iNOS and COX-2 gene expression via suppression of nuclear factor-kappaB activation.  Biochem Pharmacol. 2000;  59 1445-57
• 13 Sirois J, Levy L O, Simmons D L, Richards J S. Characterization and hormonal regulation of the promoter of the rat prostaglandin endoperoxide synthase 2 gene in granulosa cells. Identification of functional and protein-binding regions.  J Biol Chem. 1993;  268 12 199-206
• 14 Saunders M A, Sansores-Garcia L, Gilroy D W, Wu K K. Selective suppression of CCAAT/enhancer-binding protein beta binding and cyclooxygenase-2 promoter activity by sodium salicylate in quiescent human fibroblasts.  J Biol Chem. 2001;  276 18 897-904
• 15 Wang C Y, Lei H J, Huang C Y, Zhang Z, Mukherjee A B, Yuan C J. Induction of cyclooxygenase-2 by staurosporine through the activation of nuclear factor for IL-6 (NF-IL6) and activator protein 2 (AP2) in an osteoblast-like cell line.  Biochem Pharmacol. 2002;  64 177-84
• 16 Yamamoto K, Arakawa T, Ueda N, Yamamoto S. Transcriptional roles of nuclear factor κB and nuclear factor-interleukin-6 in the tumor necrosis factor α-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells.  J Biol Chem. 1995;  270 31 315-20
• 17 Inoue H, Umesono K, Nishimori T, Hirata Y, Tanabe T. Glucocorticoid-mediated suppression of the promoter activity of the cyclooxygenase-2 gene is modulated by expression of its receptor in vascular endothelial cells.  Biochem Biophys Res Commun. 1999;  254 292-8
• 18 Hattori T, Ohoka N, Hayashi H, Onozaki K. C/EBP homologous protein (CHOP) up-regulates IL-6 transcription by trapping negative regulating NF-IL6 isoform.  FEBS Lett. 2003;  541 33-9
• 19 Lee A K, Sung S H, Kim Y C, Kim S G. Inhibition of lipopolysaccharide-inducible nitric oxide synthase, TNF-α and COX-2 expression by sauchinone effects on I-κBa phosphorylation, C/EBP and AP-1 activation.  Br J Pharmacol. 2003;  139 11-20
• 20 Wardlaw S A, Zhang N, Belinsky S A. Transcriptional regulation of basal cyclooxygenase-2 expression in murine lung tumor-derived cell lines by CCAAT/enhancer-binding protein and activating transcription factor/cAMP response element-binding protein.  Mol Pharmacol. 2002;  62 326-33
• 21 Faussner A, Bauer A, Kalatskaya I, Jochum M, Fritz H. Expression levels strongly affect ligand-induced sequestration of B2 bradykinin receptors in transfected cells.  Am J Physiol Heart Circ Physiol. 2003;  284 1892-8